StockPlus Financial Services

News Details

( As on 22/07/2026 19:13)

Bliss GVS Pharma - Updates

Bliss GVS Pharma Limited has informed the Exchange regarding 'the intimation of recommendations by the Committee of Independent Directors pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 on Open Offer made by the Anupam Rasayan India Limited together with PAC to the Public Shareholders of the Bliss GVS Pharma Limited.'

IPO

News

Links to Exchanges

Designed, Developed and Content Provided by DION

StockPlus Financial Services SEBI Registration No. (BSE Cash / BSE F&O / NSE Cash / MSEI Cash / MSEI F&O) : INZ000227218
NSE Registration Member No. : 90045 & BSE Registration Member No. : 6156 FILING COMPLAINTS ON SCORES

Mutual Fund | ARN 36577 | Website : www.stockplus.co.in
Existing customers can send their grievances to : grievances@stockplus.co.in
Compliance Officer : Mr. Bipin M. Savla, 4013 9900, email : bmsavla@stockplus.co.in

Attention Investors Attention Investors : 1) KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | 2) Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors. | 3) Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 4) Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 5) Pay 20% upfront margin of the transaction value to trade in cash market segment. | 6) Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.